Using cell-specific AR knockout (ARKO) mouse models (12) and the newly developed AR degradation enhancer, ASC-J9 (12, –, 15), we demonstrated that the AR in hepatocytes and kidney epithelial cells promotes oxalate/CaOx formation in the early stages of kidney stone formation. The gene discussed is AR; the disease is nephrolithiasis.